Experts in the spotlight – Krka’s symposium in London

Expertise from real-life clinical practice in the treatment of cardiovascular diseases was shared at Krka’s symposium Experts in the spotlight.

The symposium was held on 29 August in London during the Congress of the European Society of Cardiology. Krka’s Medical Director Breda Barbič-Žagar welcomed almost 230 top-level medical doctors and key opinion leaders from 20 countries and introduced our company and how we develop our high-quality cardiovascular medicines.

She emphasized that the keys to success are knowledge and innovation. With a desire to get closer to the patients, and to facilitate their treatment, we produce medicines in advanced pharmaceutical forms, and by introducing new strengths and fixed-dose combinations we expand treatment possibilities. The main purpose of Krka’s medicines is effective, safe and quality treatment, tailored to the needs of each patient. Every day almost 16 million patients are treated with Krka’s cardiovascular medicines.

The scientific part of the symposium was performed as a panel discussion among Associate Professor Nebojša Tasić from Serbia, Professor Ion Bruckner from Romania, Nena Kopčavar Guček from Slovenia, Professor Zbigniew Antoni Gaciong from Poland and Professor Oxana Drapkina from Russia. At the symposium the experts touched on one of the most current cardiovascular topics by referring to actual patient cases. The audience also participated in the panel discussion and took the opportunity to discuss and exchange experiences, suggestions and opinions with doctors from all over the world.

The panel discussion was excellently moderated by Professor Marko Noč from Slovenia.

Krka’s international symposium was dedicated to the challenges doctors face in daily clinical practice. We have put experts in the spotlight to find the best solutions and the best treatment options for our patients.